Angiology Department, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Vasc Med. 2023 Oct;28(5):404-411. doi: 10.1177/1358863X231191908. Epub 2023 Aug 29.
Functional performance is impaired in patients with peripheral artery disease (PAD). The effects of a supervised exercise training (SET) program on functional performance have yet to be clearly determined. The aim was to investigate the time-course evolution of functional performance during a 3-month SET program.
Patients with chronic symptomatic PAD participating in a 3-month SET program were investigated. Six-minute walking distance (6MWD), the stair climbing test (SCT), and the Short Physical Performance Battery (SPPB) were assessed before SET, after the first and second months of SET, and following the SET program. The ankle- and toe-brachial indices were measured before and after the SET program.
Ninety patients with PAD (age 65.4 ± 10.2 years) were analyzed. The 6MWD significantly improved after the first (+7%, ⩽ 0.001) and second months (+13%, ⩽ 0.001) and following SET (+14%, ⩽ 0.001) compared to before the SET program. The 6MWD significantly improved after the 2nd month (+6%, ⩽ 0.001) and following SET (+7%, ⩽ 0.001) compared to after the first month of the SET program. The SPPB score and SCT performance significantly improved after the first (SPPB score: +9%, ⩽ 0.001; SCT: +17%, ⩽ 0.001) and second months (SPPB score: +11%, ⩽ 0.001; SCT: +24%, ⩽ 0.001) and following SET (SPPB score: +12%, ⩽ 0.001; SCT: +25%, ⩽ 0.001) compared to before the SET program. No significant differences were observed following SET compared to the second month of the SET program. Vascular parameters did not change significantly.
A 3-month SET program improves several components of functional performance, and adaptations mainly occur during the 1st and 2nd months of the SET program.
外周动脉疾病(PAD)患者的功能表现受损。监督运动训练(SET)方案对功能表现的影响尚未明确确定。目的是研究 3 个月 SET 方案期间功能表现的时间过程演变。
研究了参加 3 个月 SET 方案的慢性有症状 PAD 患者。在 SET 之前、SET 的第一个和第二个月之后以及 SET 之后评估了 6 分钟步行距离(6MWD)、楼梯攀登测试(SCT)和简短身体表现电池(SPPB)。在 SET 前后测量了踝臂指数和趾臂指数。
分析了 90 名 PAD 患者(年龄 65.4 ± 10.2 岁)。与 SET 前相比,SET 后的第一个月(+7%, ⩽ 0.001)和第二个月(+13%, ⩽ 0.001)以及 SET 后(+14%, ⩽ 0.001)6MWD 显著改善。与 SET 后的第一个月相比,SET 后的第二个月(+6%, ⩽ 0.001)和 SET 后(+7%, ⩽ 0.001)6MWD 显著改善。与 SET 前相比,SET 后的第一个月(SPPB 评分:+9%, ⩽ 0.001;SCT:+17%, ⩽ 0.001)和第二个月(SPPB 评分:+11%, ⩽ 0.001;SCT:+24%, ⩽ 0.001)以及 SET 后(SPPB 评分:+12%, ⩽ 0.001;SCT:+25%, ⩽ 0.001)SPPB 评分和 SCT 性能显著提高。SET 后与 SET 后的第二个月相比,没有观察到显著差异。血管参数没有显著变化。
3 个月的 SET 方案可改善功能表现的几个方面,并且适应主要发生在 SET 方案的第 1 个月和第 2 个月。